Plan treatment with clarity,
not guesswork

When you clearly see how each patient's body processes medications differently,
prescribing stops being trial and error and starts getting personal.

Request Demo

Medication decisions are complex. The guidance shouldn't be.

Medications selected by trial and error rather than individual biology

Genetic insights are too complex to act on when you need them

Patient history and test results scattered across systems and relevance

Adverse drug events that could have been anticipated and prevented

HOW EMYRA WORKS

From data to decision in three steps.

Emyra sits between testing and prescribing, connecting scattered genetic, medication, and outcomes data into usable clinical insights that fit your workflow.

1
2
3

Bring the full picture together

Genetic information and medication history arrive in one secure, unified platform.

Turn complexity into clarity

Emyra translates that data into evidence-based medication insights clinicians can trust and act on.

Stay current as care evolves

As medications, conditions, and patient responses change, insights update automatically to support longitudinal medication review.
1
2
3

Bring the full picture together

Genetic information and medication history arrive in one secure, unified platform.

Turn complexity into clarity.

Emyra translates that data into evidence-based medication insights clinicians can trust and act on.

Stay current as care evolves.

As medications, conditions, and patient responses change, insights update automatically to support ongoing, informed decisions.

Emyra saves an estimated $3,000 per patient

Built with and for healthcare providers. Designed to improve outcomes.

Safer prescribing

Reduce adverse drug events with patient-specific medication insights.
PGx-informed and evidence-based recommendations, every time.

Faster path to the right treatment

Spend less time cycling through treatments that don't fit. When alternatives exist, Emyra surfaces them ranked by safety, efficacy, and individual genetic profile.

Built to integrate, not complicate

Emyra connects with your existing EHR and delivers comprehensive intelligence directly within your clinical workflow. The result is more informed, more personalized prescribing without adding time to your day.

Emyra helps reduce avoidable costs tied to adverse drug events, repeat visits, and ineffective prescribing. The result is better care, delivered faster.

Built for Real-World Care

Emyra is built for health systems, clinics, specialty practices, and integrated care teams managing patients with complex or evolving medication needs.

Pharmacogenomics can change the prescribing equation wherever trial and error carries a high cost:

Autism Care & I/DD

Patients with autism and intellectual and developmental disabilities are among the most medication-sensitive populations in any care setting. Behavioral medications, antiepileptics, and mood stabilizers are frequently prescribed and frequently adjusted with limited visibility into how each patient's genetics shapes their response.

Geriatric Care

Older adults managing multiple chronic conditions carry the highest risk of adverse drug events of any population. As medications accumulate and interact over time, genetic variation in metabolism compounds that risk. Continuous monitoring across the full medication profile, not just individual prescriptions, is where the difference is made.

Behavioral Health

Psychiatric medications have among the highest rates of treatment failure and discontinuation of any drug class. Genetic variation in key metabolic pathways determines whether a patient reaches therapeutic levels at a standard dose, and identifying that variation before the first prescription is written changes the entire treatment trajectory.

Rural Health

Rural patients have less tolerance for a failed prescription. Longer distances to specialists, fewer follow-up touchpoints, and limited access to rapid medication adjustment make getting the right drug and dose at the first decision more important than anywhere else in the care continuum.

Oncology & Cancer Care

Cancer patients are often prescribed medications with narrow therapeutic windows where genetic variation in metabolism can mean the difference between toxicity and efficacy. Bringing pharmacogenomic intelligence into the oncology workflow, before the first cycle, not after a reaction, is where it has the most clinical impact.

Cardiovascular & Chronic Disease

Statins, anticoagulants, antihypertensives, and diabetes medications are among the most prescribed drug classes in the country and among those most affected by pharmacogenomic variation. For patients managing multiple chronic conditions simultaneously, a continuously updated medication intelligence layer that evolves with the regimen is the missing piece.

Safer medication decisions are possible.

See how Emyra makes it happen.

Request Demo